Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Management of Esophageal Varices

Introduction to Management

  • The American Association for the Study of Liver Diseases recommends the combination of nonselective beta-blockers plus endoscopic variceal ligation (EVL) as the most effective approach for managing esophageal varices, particularly for secondary prophylaxis after a bleeding episode 1, 2

Acute Variceal Bleeding Management

  • The American Association for the Study of Liver Diseases suggests that immediate resuscitation with intravascular volume support and blood transfusions should be initiated, maintaining hemoglobin at approximately 8 g/dL, in patients with acute variceal bleeding 3
  • The American Association for the Study of Liver Diseases recommends that vasoactive drugs, such as somatostatin, octreotide, or terlipressin, should be started as soon as variceal bleeding is suspected, even before diagnostic endoscopy, and continued for 3-5 days 3, 4
  • The American Association for the Study of Liver Diseases advises that short-term antibiotic prophylaxis, with oral norfloxacin or IV ciprofloxacin, is essential in all cirrhotic patients with GI hemorrhage 3, 4
  • The American Association for the Study of Liver Diseases recommends that emergency endoscopy should be performed within 12 hours to diagnose and treat variceal hemorrhage with EVL or sclerotherapy 3

Primary Prophylaxis

  • The American Association for the Study of Liver Diseases recommends that nonselective beta-blockers are the gold standard for preventing first variceal hemorrhage in patients with medium/large varices 5, 6
  • The American Association for the Study of Liver Diseases suggests that beta-blockers are indicated for patients with small varices who have high bleeding risk, such as Child B/C cirrhosis or red wale marks 6

Secondary Prophylaxis

  • The American Association for the Study of Liver Diseases recommends that the combination of nonselective beta-blockers plus EVL is superior to either therapy alone for preventing rebleeding, with rebleeding rates of 14-23% for combination therapy versus 38-47% for EVL alone 1, 7, 2
  • The American Association for the Study of Liver Diseases advises that beta-blockers should be titrated to the maximal tolerated dose rather than targeting a specific heart rate reduction 1, 6

Endoscopic Variceal Ligation (EVL) Technique

  • The American Association for the Study of Liver Diseases recommends that EVL is superior to sclerotherapy for preventing variceal rebleeding, with fewer complications 1

Special Considerations for Gastric Varices

  • The American Association for the Study of Liver Diseases suggests that gastric variceal obturation with tissue adhesives, such as N-butyl-cyanoacrylate, is more effective than EVL for gastric variceal bleeding, with significantly lower rebleeding rates 3

Monitoring and Follow-up

  • The American Association for the Study of Liver Diseases recommends that HVPG response to beta-blockers is the best predictor of clinical efficacy, with patients having a reduction to <12 mmHg or by >20% from baseline having the lowest rebleeding rate of approximately 10% 7, 2
  • The American Association for the Study of Liver Diseases advises that after variceal eradication with EVL, endoscopy should be performed every 3-6 months to evaluate for variceal recurrence 7, 3

Pitfalls to Avoid

  • The American Association for the Study of Liver Diseases recommends that beta-blockers should not be used during acute bleeding episodes, as they can decrease blood pressure and blunt physiologic heart rate response 2, 4
  • The American Association for the Study of Liver Diseases advises that contraindications to beta-blockers, including asthma, severe COPD, heart block, significant bradycardia, hypotension, and decompensated heart failure, should be recognized 2, 6